Skin cancer profiling by multiplex detection

Driven by FDA, NCCN, and ASCO guidelines, our MELANOMASEQ testing results associate Standard of Care specific to skin cancers with a focus on prioritization and support of treatment planning for the physician.

  • Comprehensive and integrated services mobilizing complete workups by IHC or Next Generation Sequencing
  • Available individual markers, reflexive offerings, and flexible testing designed to meet the cost efficiencies and clinical needs for the patient and physician
  • In-network with most managed care providers

Learn more about our MELANOMASEQ testing services.

How To Order
Test Directory